Hotimah M. Salim
Tokushima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Blood biomarkers representing maternal-fetal interface tissues used to predict early-and late-onset preeclampsia but not COVID-19 infection.
Journal: Computational and structural biotechnology journal
Published: June 27, 2022
Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice.
Journal: Journal of atherosclerosis and thrombosis
Published: February 27, 2020
Thrombin inhibition by dabigatran attenuates endothelial dysfunction in diabetic mice.
Journal: Vascular pharmacology
Published: January 15, 2019
Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice.
Journal: Atherosclerosis
Published: October 17, 2017
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.
Journal: Diabetology & metabolic syndrome
Published: August 06, 2017
Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus.
Journal: Advances in therapy
Published: August 06, 2017
Gender-linked impact of epicardial adipose tissue volume in patients who underwent coronary artery bypass graft surgery or non-coronary valve surgery.
Journal: PloS one
Published: January 08, 2017
Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.
Journal: Vascular pharmacology
Published: November 14, 2016
Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse.
Journal: Frontiers in cardiovascular medicine
Published: July 22, 2016
Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice.
Journal: Vascular pharmacology
Published: June 20, 2015
Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus.
Journal: Diabetes & metabolism journal
Published: October 28, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026